ISDA: 6I82

Deposition Date 2018-11-19

Release Date 2020-03-11

Last Version Date 2024-11-20

Entry Detail

PDB ID:

6I82

Keywords:

ONCOPROTEIN

Title:

Crystal structure of partially phosphorylated RET V804M tyrosine kinase domain complexed with PDD00018412

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Homo sapiens

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.05 Å

R-Value Free:

0.22

R-Value Work:

0.17

R-Value Observed:

0.17

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Proto-oncogene tyrosine-protein kinase receptor Ret
Gene (Uniprot):RET
Mutagens:V804M
Chain IDs:A, B
Chain Length:314
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P07949 Pfam ID:PF07714 EC:2.7.10.1

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
PTR	A	TYR	modified residue

Ligand Molecules

EDO

FMT

H6W

Primary Citation

Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RETV804MKinase.

Newton, R, Waszkowycz, B, Seewooruthun, C, Burschowsky, D, Richards, M, Hitchin, S, Begum, H, Watson, A, French, E, Hamilton, N, Jones, S, Lin, L.Y, Waddell, I, Echalier, A, Bayliss, R, Jordan, A.M, Ogilvie, D.Show

Acs Med.Chem.Lett. 11 497 505 (2020)

PMID: 32292556 DOI: 10.1021/acsmedchemlett.9b00615

Abstact

A combination of focused library and virtual screening, hit expansion, and rational design has resulted in the development of a series of inhibitors of RETV804M kinase, the anticipated drug-resistant mutant of RET kinase. These agents do not inhibit the wild type (wt) isoforms of RET or KDR and therefore offer a potential adjunct to RET inhibitors currently undergoing clinical evaluation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form